Medicare Advantage
The Centers for Medicare & Medicaid Services issued a Health Plan Management System memo to all Medicare Advantage Organizations and Medicare-Medicaid Plans to strongly encourage them to waive or relax plan prior authorization requirements and utilization management processes to facilitate the…
The AHA today expressed support for the Improving Seniors’ Timely Access to Care Act of 2021 (H.R. 3173), bipartisan legislation that would establish requirements for the use of prior authorization under Medicare Advantage plans.
The ºÚÁÏÕýÄÜÁ¿ Association voices support of the Improving Seniors’ Timely Access to Care Act of 2021 (H.R. 3173).
Resources from the Hospice and Home Health Challenges with Medicare Advantage member call, March 30, 2021.
The AHA urged the Centers for Medicare & Medicaid Services to use its oversight authority for Medicare Advantage, Medicaid managed care, Children’s Health Insurance Program and Health Insurance Marketplace health plans to prevent UnitedHealthcare from implementing certain diagnostic and…
The Centers for Medicare & Medicaid Services finalized additional provisions for the Medicare Advantage and Part D prescription drug programs beginning in 2022.
AHA comments on CMS’ proposed rule on prior authorization.
The Centers for Medicare & Medicaid Services released a request for applications from Medicare Advantage and prescription drug plans to participate in the Value-Based Insurance Design Model, including its hospice benefit component, in calendar year 2022.
AHA's comments on the Centers for Medicare & Medicaid Services’ proposed rule regarding treatment of Medicare Advantage (MA)/Medicare Part C data in calculating a hospital’s disproportionate patient percentage (DPP) for fiscal years preceding fiscal year (FY) 2014.
The Centers for Medicare & Medicaid Services announced premium and cost-sharing information for Medicare Advantage and Part D prescription drug plans for the 2021 calendar year.